Vicarious Surgical (RBOTW) Interest & Investment Income (2020 - 2025)
Vicarious Surgical (RBOTW) reported Interest & Investment Income of $158000.0 for Q3 2025, down 80.3% year-over-year from $802000.0 in Q3 2024, and down 40.15% on a QoQ basis from $264000.0 in Q2 2025.
Vicarious Surgical (RBOTW) has 6 years of Interest & Investment Income data on file, last reported at $158000.0 in Q3 2025.
- Quarterly Interest & Investment Income fell 80.3% year-over-year to $158000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.5 million (down 60.07% YoY) and the FY2024 annual result came in at $3.3 million, down 25.74% from the prior year.
- Interest & Investment Income retreated to $158000.0 in Q3 2025 per RBOTW's latest filing, from $264000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.5 million in Q1 2023 and bottomed at -$1000.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $494000.0 (2022), against an average of $528473.7.
- The widest annual swing landed in 2021, when Interest & Investment Income slumped 200.0%; it then soared 49500.0% in 2022.
- Tracing RBOTW's Interest & Investment Income over 5 years: stood at $19000.0 in 2021, then surged by 4278.95% to $832000.0 in 2022, then increased by 16.11% to $966000.0 in 2023, then plunged by 38.51% to $594000.0 in 2024, then slumped by 73.4% to $158000.0 in 2025.
- Per Business Quant, the three latest RBOTW Interest & Investment Income figures stand at $158000.0 (Q3 2025), $264000.0 (Q2 2025), and $446000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 446,000.00 |
| Dec 31, 2024 | 594,000.00 |
| Sep 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 918,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 832,000.00 |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 1,000.00 |